To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Lyra Therapeutics pockets $30 mln Series C
Watertown, Massachusetts-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has raised $30 million in Series C financing.
